| Literature DB >> 23469220 |
Martin Czerny1, Ilan Barchichat, Katharina Meszaros, Gottfried H Sodeck, Alberto Weber, David Reineke, Lars Englberger, Florian Schönhoff, Alexander Kadner, Hansjörg Jenni, Jürg Schmidli, Thierry P Carrel.
Abstract
OBJECTIVE: To evaluate early and mid-term results in patients undergoing proximal thoracic aortic redo surgery.Entities:
Mesh:
Year: 2013 PMID: 23469220 PMCID: PMC3585872 DOI: 10.1371/journal.pone.0057713
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Descriptive characteristics of the cohort.
| N overall = 60 | |||
|
| |||
| Age, median (IQR) | 60 | (51–73) | |
| Female, n (%) | 7 | (12%) | |
|
| |||
| Hypertension, n (%) | 49 | (82%) | |
| Chronic obstructive pulmonary disease, n (%) | 7 | (12%) | |
| Diabetes mellitus, n (%) | 4 | (7%) | |
| Serum creatinine >200 mmol/l, n (%) | 10 | (17%) | |
| Coronary artery disease, n (%) | 23 | (38%) | |
| Extracardiac arteriopathy, n (%) | 1 | (2%) | |
| Pulmonary hypertension, n (%) | 7 | (12%) | |
| Recent myocardial infarction, n (%) | 3 | (5%) | |
| Permanent neurologic deficit, n (%) | 16 | (27%) | |
| Connective tissue disease, n (%) | 4 | (7%) | |
| Logistic EUROSCORE, median (IQR) | 40 | (20–67) | |
| Additional EUROSCORE, median (IQR) | 12 | (10–16) | |
| EUROSCORE II, median (IQR) | 14 | (10–28) | |
|
| |||
| Aortic dissection, n (%) | 33 | (55%) | |
| Isolated aortic aneurysm, n (%) | 13 | (21%) | |
| Aortic valve stenosis with ascending disease, n (%) | 7 | (12%) | |
| Aortic valve insufficiency with ascending disease, n (%) | 4 | (7%) | |
| Other, n (%) | 3 | (5%) | |
|
| |||
| Ascending aortic replacement, n (%) | 15 | (25%) | |
| Root replacement, n (%) | 16 | (27%) | |
| Ascending and (hemi)-arch repair, n (%) | 17 | (28%) | |
| Other, n (%) | 12 | (20%) | |
Unless otherwise indicated, data are number (percentage). IQR, interquartile range; classification of chronic health conditions and risk factors according to EuroSCORE criteria.
Surgical characteristics of the cohort.
| N overall = 60 | |||
|
| |||
| Post- dissection aneurysm, n (%) | 10 | (17%) | |
| Aortic aneurysm, n (%) | 8 | (13%) | |
| Aortic rupture, n (%) | 3 | (5%) | |
| Graft infection/endocarditis, n (%) | 21 | (35%) | |
| Anastomotic aneurysms/rupture, n (%) | 12 | (20%) | |
| Other, n (%) | 6 | (10%) | |
|
| |||
| Urgent or emergent surgery, n (%) | 30 | (50%) | |
|
| |||
| Axillary/subclavian cannulation, n (%) | 24 | (40%) | |
| Direct aortic cannulation, n (%) | 27 | (45%) | |
| Partial root/ascending replacement only, n (%) | 21 | (35%) | |
| Elephant trunk, n (%) | 3 | (5%) | |
| Frozen elephant trunk, n (%) | 2 | (3%) | |
| Hemiarch replacement, n (%) | 26 | (43%) | |
| Total arch replacement, n (%) | 8 | (13%) | |
| Root replacement, n (%) | 25 | (42%) | |
| Re-implantation of trunk/arch vessels, n (%) | 12 | (20%) | |
|
| |||
| CABG, n (%) | 9 | (15%) | |
| Aortic valve replacement, n (%) | 40 | (67%) | |
| Mitral valve repair/replacement, n (%) | 6 | (10%) | |
|
| |||
| ECC in minutes, median (IQR) | 150 | (85–216) | |
| Aortic crossclamp times in minutes,median (IQR) | 93 | (62–137) | |
| DHCA in minutes, median (IQR) | 23 | (10–35) | |
Unless otherwise indicated, data are number (percentage). IQR, interquartile range; classification of chronic health conditions and risk factors according to EuroSCORE criteria.
Outcome characteristics of the cohort.
| N overall = 60 | |||
|
| |||
| In-hospital mortality, n (%) | 8 | (13%) | |
| Acute renal failure, n (%) | 6 | (10%) | |
| Pulmonary complications, n (%) | 2 | (3%) | |
| Acute myocardial infarction, n (%) | 1 | (2%) | |
| New neurologic deficit, n (%) | 4 | (7%) | |
| Sepsis, n (%) | 3 | (5%) | |
|
| |||
| Follow-up in months, median (IQR) | 23 | (1–52) | |
| Late death, n (%) | 13 | (22%) | |
| Need for re-intervention, n (%) | 0 | (0%) | |
Unless otherwise indicated, data are number (percentage). IQR, interquartile range; classification of complications according to STS criteria.
Distribution of patients by different chronic health conditions and in-hospital risk assessment stratified to in-hospital outcome.
| Death (N = 8) vs. Survival (N = 52) | P | ||||
|
| |||||
| Age, median (IQR) | 76 (58–80) | 60 (49–70) | 0.02 | ||
| Female sex, n (%) | 2 (25%) | 5 (10%) | 0.21 | ||
|
| |||||
| Hypertension, n (%) | 8 (100%) | 41 (79%) | 0.17 | ||
| Chronic obstructive pulmonary disease, n (%) | 2 (25%) | 5 (10%) | 0.21 | ||
| Diabetes mellitus, n (%) | 1 (13%) | 3 (6%) | 0.49 | ||
| Serum creatinine >200 mmol/l,n (%) | 2 (22%) | 8 (15%) | 0.50 | ||
| Coronary artery disease, n (%) | 5 (63%) | 18 (35%) | 0.14 | ||
| Extracardiac arteriopathy, n (%) | 0 (0%) | 1 (2%) | 0.69 | ||
| Pulmonary hypertension, n (%) | 3 (38%) | 4 (8%) | 0.014 | ||
| Permanent neurologic deficit,n (%) | 2 (25%) | 14 (27%) | 0.90 | ||
| Connective tissue disease, n (%) | 0 (0%) | 4 (8%) | 0.44 | ||
|
| |||||
| Critical preoperative state, n (%) | 5 (63%) | 9 (17%) | 0.005 | ||
| Recent myocardial infarction, n (%) | 1 (13%) | 2 (2%) | 0.27 | ||
| Logistic EUROSCORE, median, (IQR) | 83 (63–95) | 34 (20–59) | 0.004 | ||
| Additive EUROSCORE, median (IQR) | 17 (12–23) | 12 (10–15) | 0.011 | ||
| EUROSCORE II, median (IQR) | 41 (21–67) | 13 (10–20) | 0.001 | ||
|
| |||||
| Root replacement, n (%) | 3 (38%) | 22 (42%) | 0.80 | ||
| DHCA in minutes, median (IQR) | 33 (24–48) | 22 (9–32) | 0.14 | ||
Unless otherwise indicated, data are number (percentage). IQR, interquartile range; ECC, extracorporal circulation; HCA, hypothermic circulatory arrest; classification of chronic health conditions and risk factors according to EuroSCORE criteria.
Figure 1Logistic regression model to assess the predictive power of EuroSCORE I levels.
Figure 2One year and five year actuarial survival rates.